Search & read
310 bilingual monographs in content edition 10.0. Search by ingredient, title or dosage form and open the relevant record.
Search the formularySIKALIAS · KNOWLEDGE IN PRACTICE
Scientific projects & development
Stasinos Chr. Sikalias: Greek Formulary Sikalias and EIREN/Firmie cosmetic development projects.
Greek Formulary Sikalias
Collection and documentation of compounded preparations, edited by Stasinos Chr. Sikalias. The project connects source review with search tools, arithmetic formula scaling and controlled laboratory records.
An independent scientific initiative. Content edition 10.0 · website revision 11.0. See compounding.gr for current edition details, authorship and review status.
Formula scaling
Arithmetic scaling where the source batch basis is explicit. It preserves q.s. and does not convert mass to volume, set patient doses or establish beyond-use dates.
Methodology & limitsSOPs & records
36 SOPs and 22 blank forms supporting documentation, checks and adaptation to the local laboratory.
Quality systemEvidence decisions
Review each monograph’s current decision and supporting sources in the decision register. Editorial review and reference publication do not establish validation of a laboratory’s own batch.
Review closure criteriaFrom a scientific question to product development
As Managing Director & R&D Manager of Sikalias Pharmaceutical Laboratories, Stasinos Chr. Sikalias connects product strategy with development planning and coordination. EIREN and Firmie are being developed by Sikalias Pharmaceutical Laboratories. They are not yet available for sale and no launch date has been announced.
EIREN
Baby care with short formulas and ingredients also used in foods, assessed for their cosmetic application. External-use cosmetics, not products to ingest.
Explore EIRENFirmie
Facial serum development: FIRM 5 as the core step and NIGHT 0.1 as an optional evening product. Published ingredient research guides design; finished-product performance requires its own testing.
Explore FirmieSIKALIAS PHARMACEUTICAL LABORATORIES
Turn a scientific question into a development brief.
Discuss formulation R&D, technology transfer, CMO / CDMO or European nearshoring with the Laboratories. Start with a non-confidential outline of your dosage form, development stage, target market and volume.